16 results about "Meter dose inhaler" patented technology

An improved stem block for an inhaler that is fired in an upright orientation, providing easier and more reliable delivery of aerosols. The disclosed stem block demonstrates atomization efficiency that is superior to the performance of a conventional metered dose inhaler. The stem block has a passage that connects to a narrower expansion chamber. The expansion chamber connects to an exit orifice that is narrower than the expansion chamber. The exit orifice further connects to a conical outlet for dispensing an aerosol. The passage, the expansion chamber, and the exit orifice are axially aligned.

An electronic module for a metered dose inhaler comprises a housing (10) having a front wall (13) configured to face a rear side (6a) of a housing (6) of the metered dose inhaler (2), a rear wall (16) opposite the front wall (13), and a side wall (17) extending between the front wall (13) and the rear wall (16). An electronics unit (11) is mounted inside the housing (10) and comprises a capacitive proximity device (29) with a capacitive sensor antenna (30). The capacitive sensor antenna (30) is disposed against or near an inner surface of a rear wall (16) and / or a side wall (17) of the housing (10).

The present invention relates to a device (20) for delivering a medicament (30) to a user via the nasal or pulmonary route. The device may be a pressurized metered dose inhaler (200), an active dry powder inhaler (300 / 400), a soft mist inhaler (500), or a nebulizer (600). The device (20) comprises a propellant energy source (40) for delivering the medicament (30), the propellant energy source (40) being or comprising an atmospheric gas (41) stored in a canister (45) separate from the medicament, adsorbed on an adsorbate (42) at a pressure of at least 2 bar, the atmospheric gas being released from the canister to dispense the medicament (30). The device includes a gas delivery mechanism (50) having a metering chamber (52) that has a greater capacity than a conventional pressurized metered dose inhaler filled with HFC propellant. The atmospheric-like gas (41), upon actuation, is released from the chamber and travels along the conduit (25) to displace a dose of medicament (30) from the dose chamber (80) undergoing aerosolization and exit the device as a plume (60) via a second conduit (27) and an outlet (28).

The invention relates to metered dose inhaler comprising a stable pharmaceutical composition of fluticasone or its pharmaceutically acceptable ester contained in a canister fitted with a metering valve, an actuator and dose counter. The invention also relates to a process for preparing said pharmaceutical composition and its use in the treatment of respiratory disorders such as asthma in a subject (e.g., a human).

Various embodiments of a metered dose inhaler are disclosed. The inhaler includes a metering valve, a canister, and an actuator having an actuator nozzle. The canister includes a formulation having a propellant including HFO-1234ze(E), at least 1% of ethanol by weight, and one or more cannabinoids, wherein the one or more cannabinoids is dissolved in the formulation to form a solution. In one or more embodiments, the cannabinoid includes tetrahydrocannabinol (THC) and / or cannabidiol (CBD).

A pressurised metered dose inhaler 200, an active dry powder inhaler, a soft mist inhaler or a nebuliser comprising a device 20 comprising canister walls 23 and an end face 24. The inhaler comprises a

The present invention relates to a metered dose inhaler device comprising a stable inhalable composition of ipratropium bromide, contained in a canister fitted with a metering valve, an actuator and a dose indicator. The present invention also relates to a process for preparing such a pharmaceutical composition and its use in the treatment of respiratory disorders such as for the maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema in a subject in need thereof (e.g., a human).

Various embodiments of a metered dose inhaler are disclosed. The inhaler includes a metering valve, a canister, and an actuator having an actuator nozzle. The canister contains a formulation having a propellant including HFA-152a, at least 1% by weight ethanol, and one or more cannabinoids, the one or more cannabinoids dissolved in the formulation to form a solution. In one or more embodiments, the cannabinoids include tetrahydrocannabinol (THC) and / or cannabidiol (CBD).

Various embodiments of a metered dose inhaler are disclosed. The inhaler includes a metering valve, a canister, and an actuator having an actuator nozzle. The canister includes a formulation having a propellant including HFA-152a, at least 1% of ethanol by weight, and one or more cannabinoids, wherein the one or more cannabinoids is dissolved in the formulation to form a solution. In one or more embodiments, the cannabinoid includes tetrahydrocannabinol (THC) and / or cannabidiol (CBD).

Pharmaceutical aerosol formulations containing pre-micronized albuterol sulfate, high amount of green propellant trans-1,3,3,3-tetrafluoropropene (HFO-1234ze (E)), and a surfactant (polysorbate 80 (polyoxyethylene (20) sorbitan monooleate), polysorbate 20 (polyoxyethylene (20) sorbitan monolaurate), polyethylene glycol 1000, span 85 (sorbitan trioleate), polyvinylpyrrolidone K25, or their combination) in a pressurized metered dose inhaler are described. The formulations do not use any co-solvent, i.e., they are co-solvent-free (e.g., free of ethanol, glycerol, propylene glycol, and a combination thereof). The formulations provide highly efficient delivery, through metered dose inhaler (MDI), of pre-micronized albuterol particles into the patients' respiratory tracts and have the advantages of high efficacy, improved safety, and a low global warming potential (GWP) for environmental impact.

The present invention generally relates to an aerosol formulation comprising formoterol and beclomethasone dipropionate, said formulation being contained in a coated can, particularly useful for the use in a pressurised metered dose inhaler for the teratment of respiratory diseases.

The present invention generally relates to an aerosol formulation comprising formoterol, beclomethasone dipropionate and glycopyrronium bromide, said formulation being contained in a coated can, particularly useful for the use in a pressurised metered dose inhaler for the treatment of respiratory diseases.

An electronic module for a metered dose inhaler, the electronic module comprising: a housing (10) having an outer surface (17) provided with a pressure detection point (16); an electronic unit (11) and a pressure sensor (13) enclosed in the housing (10). The pressure sensor (13) is operatively connected to the electronic unit (11) and to the pressure detection point (16). The housing (10) comprises two hooks (19) configured to engage an edge (9) of a housing (6) of the metered dose inhaler (2), the housing containing a canister (5) containing the pharmaceutical preparation to be dispensed. A pressure detection point (16) is located between the two hooks (19). The electronics module is attachable to the metered dose inhaler.

Various embodiments of a metered dose inhaler are disclosed. The inhaler includes a metering valve, a canister, and an actuator having an actuator nozzle. The canister includes a composition having greater than 70% by weight of HFO-1234ze(E), PEG, and at least one active pharmaceutical ingredient suspended in the composition to form a suspension. The compositions are substantially free of ethanol.

1. The name of the design product: dosing device. 2. The use of the design product: for matching with metered dose inhaler, for use when the inhalation medicine is used immediately after spraying. 3. The design points of the design product: in shape. 4. The picture or photo that best shows the design points: design 1 perspective view. 5. Design 1 is designated as the basic design.